View in EDS HTML Full Text PDF Full Text

Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Authors: Chen, Hui-Sheng1 (AUTHOR) chszh@aliyun.com, Cui, Yu1 (AUTHOR), Zhou, Zhong-He1 (AUTHOR), Zhang, Hong2 (AUTHOR), Wang, Li-Xia3 (AUTHOR), Wang, Wei-Zhong4 (AUTHOR), Shen, Li-Ying5 (AUTHOR), Guo, Li-Yan6 (AUTHOR), Wang, Er-Qiang7 (AUTHOR), Wang, Rui-Xian8 (AUTHOR), Han, Jing9 (AUTHOR), Dong, Yu-Ling10 (AUTHOR), Li, Jing11 (AUTHOR), Lin, Yong-Zhong12 (AUTHOR), Yang, Qing-Cheng13 (AUTHOR), Zhang, Li14 (AUTHOR), Li, Jing-Yu15 (AUTHOR), Wang, Jin16 (AUTHOR), Xia, Lei17 (AUTHOR), Ma, Guang-Bin18 (AUTHOR)
Source: JAMA: Journal of the American Medical Association. 6/27/2023, Vol. 329 Issue 24, p2135-2144. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00987484
DOI:10.1001/jama.2023.7827